Home LiteratureArticle Details
PMID: 8843290 Published · ppublish English Journal Article

Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.

Antimicrobial agents and chemotherapy ·Vol. 40 ·No. 8 ·1996-08-00 ·Pages 1835-42

Takenouchi T, Tabata F, Iwata Y, Hanzawa H, Sugawara M, Ohya S

Abstract

The elevated expression of the norA gene is responsible for efflux-mediated resistance to quinolones in Staphylococcus aureus (E.Y.W. Ng, M. Trucksis, and D.C. Hooper, Antimicrob. Agents Chemother. 38:1345-1355, 1994). For S. aureus transformed with a plasmid containing the cloned norA gene, SA113(pTUS20) (H. Yoshida, M. Bogaki, S. Nakamura, K. Ubukata, and M. Konno, J. Bacteriol. 172:6942-6949, 1990), and an overexpressed mutant, SA-1199B (G.W. Kaatz, S.M. Seo, and C.A. Ruble, J. Infect. Dis. 163:1080-1086, 1991), the MICs of norfloxacin increased 16 and 64 times compared with its MICs for the recipient and wild-type strains, SA113 and SA-1199, respectively. MICs of CS-940, however, increased only two and eight times, even though these two fluoroquinolones are similarly hydrophilic (apparent logPs of approximately -1). No good correlation was found, among 15 developed and developing quinolones, between the increment ratio in MICs and hydrophobicity (r = 0.61). Analysis of the quantitative structure-activity relationship among 40 fluoroquinolones revealed that the MIC increment ratio was significantly correlated with the bulkiness of the C-7 substituent and bulkiness and hydrophobicity of the C-8 substituent of fluoroquinolones (r = 0.87) and not with its molecular hydrophobicity (r = 0.47). Cellular accumulation of norfloxacin in SA-1199B was significantly lower than that in SA-1199, and it was increased by addition of carbonyl cyanide m-chlorophenyl hydrazone. On the other hand, accumulations of CS-940 in these strains were nearly identical, and they were not affected by addition of the protonophore.

MeSH Terms
Anti-Infective Agents/chemistry,metabolism,pharmacology Bacterial Proteins/genetics,physiology Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology DNA Gyrase DNA Topoisomerase IV DNA Topoisomerases, Type II/genetics Drug Resistance, Microbial Escherichia coli/drug effects,metabolism Fluoroquinolones Microbial Sensitivity Tests Multidrug Resistance-Associated Proteins Norfloxacin/chemistry,metabolism,pharmacology Piperazines/chemistry,metabolism,pharmacology Point Mutation Quinolones/chemistry,metabolism,pharmacology Staphylococcus aureus/drug effects,metabolism Structure-Activity Relationship
Chemicals
Anti-Infective Agents Bacterial Proteins Fluoroquinolones Multidrug Resistance-Associated Proteins Piperazines Quinolones NorA protein, Staphylococcus CS 940 Carbonyl Cyanide m-Chlorophenyl Hydrazone DNA Topoisomerase IV DNA Gyrase DNA Topoisomerases, Type II Norfloxacin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Takenouchi T
Biological Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.
Tabata F
Iwata Y
Hanzawa H
Sugawara M
Ohya S
References (36)
36 references, click to expand
  1. DNA topoisomerases.
    Annu Rev Biochem. 1985;54:665-97 PMID: 2992360
  2. The twisted 'life' of DNA in the cell: bacterial topoisomerases.
    Mol Microbiol. 1995 Feb;15(4):601-6 PMID: 7783632
  3. The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis.
    J Antimicrob Chemother. 1987 Nov;20(5):753-8 PMID: 3429376
  4. Routes of quinolone permeation in Escherichia coli.
    Antimicrob Agents Chemother. 1988 Apr;32(4):438-42 PMID: 3132091
  5. Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.
    J Clin Microbiol. 1989 Feb;27(2):335-6 PMID: 2492540
  6. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.
    Antimicrob Agents Chemother. 1989 Apr;33(4):593-4 PMID: 2729953
  7. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 1989 Sep;33(9):1535-9 PMID: 2817852
  8. A point mutation in norA gene is responsible for quinolone resistance in Staphylococcus aureus.
    Biochem Biophys Res Commun. 1990 Nov 15;172(3):1028-34 PMID: 2173911
  9. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones.
    J Bacteriol. 1990 Dec;172(12):6942-9 PMID: 2174864
  10. Fluoroquinolone antimicrobial agents.
    N Engl J Med. 1991 Feb 7;324(6):384-94 PMID: 1987461
  11. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches.
    J Antimicrob Chemother. 1990 Dec;26 Suppl F:165-79 PMID: 2127272
  12. Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones.
    Antimicrob Agents Chemother. 1992 Dec;36(12):2622-7 PMID: 1336340
  13. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus.
    Antimicrob Agents Chemother. 1992 Nov;36(11):2506-11 PMID: 1489194
  14. Quinolone mode of action.
    Drugs. 1995;49 Suppl 2:10-5 PMID: 8549276
  15. Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones.
    Antimicrob Agents Chemother. 1995 Jul;39(7):1414-8 PMID: 7492077
  16. Protonation equilibria of quinolone antibacterials.
    J Pharm Sci. 1990 Nov;79(11):1023-8 PMID: 1963448
  17. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus.
    J Infect Dis. 1991 May;163(5):1080-6 PMID: 1850442
  18. Impermeability to quinolones in gram-positive and gram-negative bacteria.
    Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):232-9 PMID: 1864283
  19. A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus.
    J Bacteriol. 1991 Sep;173(18):5854-60 PMID: 1653224
  20. DNA gyrase: structure and function.
    Crit Rev Biochem Mol Biol. 1991;26(3-4):335-75 PMID: 1657531
  21. gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee.
    J Infect Dis. 1991 Nov;164(5):976-9 PMID: 1658161
  22. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus.
    J Antimicrob Chemother. 1991 Nov;28(5):639-53 PMID: 1663928
  23. Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing.
    Antimicrob Agents Chemother. 1992 May;36(5):1166-9 PMID: 1510411
  24. Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.
    Antimicrob Agents Chemother. 1992 Aug;36(8):1601-5 PMID: 1416840
  25. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.
    Antimicrob Agents Chemother. 1986 Mar;29(3):535-8 PMID: 3521490
  26. Cloning, sequencing, and expression of the DNA gyrase genes from Staphylococcus aureus.
    J Bacteriol. 1993 Jun;175(11):3269-77 PMID: 8388872
  27. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 1993 May;37(5):1086-94 PMID: 8517696
  28. Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa.
    J Antimicrob Chemother. 1993 Jun;31(6):865-80 PMID: 8360125
  29. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples.
    Antimicrob Agents Chemother. 1993 Jul;37(7):1393-9 PMID: 8363364
  30. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.
    J Antimicrob Chemother. 1993 Sep;32(3):379-92 PMID: 8262860
  31. Computer-aided analyses of transport protein sequences: gleaning evidence concerning function, structure, biogenesis, and evolution.
    Microbiol Rev. 1994 Mar;58(1):71-93 PMID: 8177172
  32. Multidrug resistance pumps in bacteria: variations on a theme.
    Trends Biochem Sci. 1994 Mar;19(3):119-23 PMID: 8203018
  33. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
    Antimicrob Agents Chemother. 1994 Jun;38(6):1345-55 PMID: 8092836
  34. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Mol Microbiol. 1994 Aug;13(4):641-53 PMID: 7997176
  35. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
    Antimicrob Agents Chemother. 1994 Sep;38(9):2014-23 PMID: 7811012
  36. The role of topoisomerase IV in partitioning bacterial replicons and the structure of catenated intermediates in DNA replication.
    Cell. 1992 Oct 16;71(2):277-88 PMID: 1330320
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1996-08-00
Pages
1835-42
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC163426
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]